Neurodevelopmental Outcomes of Anti-VEGF versus Laser Photocoagulation for Retinopathy of Prematurity: Insights from a Comprehensive Review by the American Academy of Ophthalmology

Neurodevelopmental Outcomes of Anti-VEGF versus Laser Photocoagulation for Retinopathy of Prematurity: Insights from a Comprehensive Review by the American Academy of Ophthalmology

This review synthesizes current evidence on neurodevelopmental outcomes after treating retinopathy of prematurity with anti-VEGF injections versus laser photocoagulation, finding no significant differences in long-term cognitive or developmental effects.
Baseline Deep Capillary Plexus Ischemia as a Superior Predictor of Early Diabetic Retinopathy Complications Relative to Foveal Avascular Zone Enlargement

Baseline Deep Capillary Plexus Ischemia as a Superior Predictor of Early Diabetic Retinopathy Complications Relative to Foveal Avascular Zone Enlargement

Deep capillary plexus ischemia quantified by geometric perfusion deficit predicts earlier and higher risk of diabetic retinopathy complications than foveal avascular zone enlargement, underscoring GPDd's clinical utility as a biomarker for personalized monitoring.
Optimizing IOL Power Calculation After Myopic Laser Vision Correction: Insights from a Multicenter Evaluation of 14 Formulas with Posterior Corneal Curvature Consideration

Optimizing IOL Power Calculation After Myopic Laser Vision Correction: Insights from a Multicenter Evaluation of 14 Formulas with Posterior Corneal Curvature Consideration

This large multicenter study demonstrates that modern intraocular lens power formulas, particularly those incorporating posterior corneal curvature, provide superior refractive prediction accuracy in eyes with prior myopic laser vision correction compared to early-generation formulas.
Identifying Risk Factors for Progression from Primary Angle Closure Suspect to Primary Angle Closure: Insights from the ANA-LIS Trial

Identifying Risk Factors for Progression from Primary Angle Closure Suspect to Primary Angle Closure: Insights from the ANA-LIS Trial

This post hoc analysis of the ANA-LIS trial elucidates key anterior segment anatomical and clinical predictors—including baseline intraocular pressure and plateau iris configuration—that increase the risk of progression from primary angle closure suspect (PACS) to primary angle closure (PAC) over five years.
Crowded Optic Discs and Risk Stratification of NAION in GLP-1 Receptor Agonist Users: Insights from a Large Multicenter Study

Crowded Optic Discs and Risk Stratification of NAION in GLP-1 Receptor Agonist Users: Insights from a Large Multicenter Study

This large multicenter study reveals that nonarteritic anterior ischemic optic neuropathy (NAION) patients exposed to GLP-1 receptor agonists exhibit similar optic disc crowding compared to nonexposed patients, with smaller cup-to-disc ratios strongly correlating with increased NAION risk.
Evaluating the Risk of Anterior Ischemic Optic Neuropathy with GLP-1 Receptor Agonists in Type 2 Diabetes: Insights from a Swedish Nationwide Cohort Study

Evaluating the Risk of Anterior Ischemic Optic Neuropathy with GLP-1 Receptor Agonists in Type 2 Diabetes: Insights from a Swedish Nationwide Cohort Study

A large Swedish cohort study assesses whether glucagon-like peptide-1 receptor agonists increase the risk of anterior ischemic optic neuropathy in type 2 diabetes. Although a borderline elevated relative risk was observed, absolute incidence remained low and confounding factors likely influenced results.